701 related articles for article (PubMed ID: 24119175)
1. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
[TBL] [Abstract][Full Text] [Related]
2. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
Zaak D; Burger M; Otto W; Bastian PJ; Denzinger S; Stief CG; Buchner H; Hartmann A; Wieland WF; Shariat SF; Fritsche HM
BJU Int; 2010 Aug; 106(3):342-8. PubMed ID: 20002664
[TBL] [Abstract][Full Text] [Related]
3. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
[TBL] [Abstract][Full Text] [Related]
4. External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder.
Moon KC; Kim M; Kwak C; Kim HH; Ku JH
Ann Surg Oncol; 2014 Sep; 21(9):3132-41. PubMed ID: 24590433
[TBL] [Abstract][Full Text] [Related]
5. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
7. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years.
Mmeje CO; Nunez-Nateras R; Nielsen ME; Pruthi RS; Smith A; Wallen EM; Humphreys MR; Woods ME; Castle EP
Urol Oncol; 2013 Nov; 31(8):1621-7. PubMed ID: 22534088
[TBL] [Abstract][Full Text] [Related]
9. Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.
Collins JW; Tyritzis S; Nyberg T; Schumacher M; Laurin O; Khazaeli D; Adding C; Jonsson MN; Hosseini A; Wiklund NP
Eur Urol; 2013 Oct; 64(4):654-63. PubMed ID: 23769588
[TBL] [Abstract][Full Text] [Related]
10. Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study.
Bassi PF; Bongiovanni L; Racioppi M; Volpe A; D'Agostino D; Gardi M; ;
Urol Oncol; 2011; 29(6):698-702. PubMed ID: 19959381
[TBL] [Abstract][Full Text] [Related]
11. External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy.
Brooks M; Godoy G; Sun M; Shariat SF; Amiel GE; Lerner SP
J Urol; 2016 Feb; 195(2):283-9. PubMed ID: 26343350
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
[TBL] [Abstract][Full Text] [Related]
13. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
[TBL] [Abstract][Full Text] [Related]
14. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
Coen JJ; Paly JJ; Niemierko A; Kaufman DS; Heney NM; Spiegel DY; Efstathiou JA; Zietman AL; Shipley WU
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):311-6. PubMed ID: 23474117
[TBL] [Abstract][Full Text] [Related]
15. Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy.
Simone G; Bianchi M; Giannarelli D; Daneshmand S; Papalia R; Ferriero M; Guaglianone S; Sentinelli S; Colombo R; Montorsi F; Collura D; Muto G; Novara G; Hurle R; Rink M; Fisch M; Abol-Enein H; Miranda G; Desai M; Gill I; Gallucci M
World J Urol; 2015 Oct; 33(10):1419-28. PubMed ID: 25542395
[TBL] [Abstract][Full Text] [Related]
16. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.
Aziz A; May M; Burger M; Palisaar RJ; Trinh QD; Fritsche HM; Rink M; Chun F; Martini T; Bolenz C; Mayr R; Pycha A; Nuhn P; Stief C; Novotny V; Wirth M; Seitz C; Noldus J; Gilfrich C; Shariat SF; Brookman-May S; Bastian PJ; Denzinger S; Gierth M; Roghmann F;
Eur Urol; 2014 Jul; 66(1):156-63. PubMed ID: 24388438
[TBL] [Abstract][Full Text] [Related]
17. Robotic and laparoscopic radical cystectomy for bladder cancer: long-term oncologic outcomes.
Snow-Lisy DC; Campbell SC; Gill IS; Hernandez AV; Fergany A; Kaouk J; Haber GP
Eur Urol; 2014 Jan; 65(1):193-200. PubMed ID: 24018019
[TBL] [Abstract][Full Text] [Related]
18. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
20. Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis.
Seisen T; Colin P; Hupertan V; Yates DR; Xylinas E; Nison L; Cussenot O; Neuzillet Y; Bensalah K; Novara G; Montorsi F; Zigeuner R; Remzi M; Shariat SF; Rouprêt M
BJU Int; 2014 Nov; 114(5):733-40. PubMed ID: 24447471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
